Table 3 Prevalence of renal dysfunction at different UCd levels in male and female
From: An assessment of sensitivity biomarkers for urinary cadmium burden
UCd | Male | Female | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
No. | UNAG +/− | % | Uβ2-MG +/− | % | No. | UNAG +/− | % | Uβ2-MG +/− | % | |
(0 ~ 2] | 86 | 5/81 | 5.81 | 15/71 | 17.44 | 147 | 12/135 | 8.16 | 30/117 | 20.41 |
(2 ~ 5] | 173 | 34/139 | 19.65 | 45/128 | 26.01 | 331 | 68/263 | 20.54 | 93/238 | 28.10 |
(5 ~ 10] | 242 | 71/171 | 29.34 | 97/145 | 40.08 | 377 | 152/225 | 40.32 | 188/189 | 49.87 |
(10~ | 86 | 46/40 | 53.49 | 58/28 | 67.44 | 153 | 94/59 | 61.44 | 110/43 | 71.90 |
Total | 587 | 156/431 | 26.58 | 215/372 | 36.63 | 1008 | 326/682 | 32.34 | 421/587 | 41.77 |
X2 | 56.115 | 58.462 | 130.485 | 156.434 | ||||||
p | 0.000 | 0.000 | 0.000 | 0.000 | ||||||
Linear-X2 | 52.520 | 53.353 | 128.313 | 154.094 | ||||||
p | 0.000 | 0.000 | 0.000 | 0.000 | ||||||